Opportunities for Canada to Improve Global Access to Medicines

Wojciech Copija; Lauren Degabriele; M Hosseini; Ashley Schram; Liliane Tshiama Kalonji

Opportunities for Canada to Improve Global Access to Medicines

Wojciech Copija, Lauren Degabriele, M Hosseini, Ashley Schram, Liliane Tshiama Kalonji

Research output: Book/Report › Commissioned report › peer-review

Abstract

This report explores a number of drug development and delivery models for the Canadian government to consider implementing as it looks to improve access to essential medicines both domestically and internationally. Four market-level case studies focus on innovative financing and collaborative initiatives as ways to enhance Canadas global standing on pharmaceutical R&D. One patient-level case study considers international legislation as a model to improve Canadas purchasing power.

Original language	English
Place of Publication	Ottawa, Canada
Commissioning body	Global Strategy Lab
Publication status	Published - 2016

Cite this

@book{3203e69f649e4e3ea6ccf3f397bf94d1,

title = "Opportunities for Canada to Improve Global Access to Medicines",

abstract = "This report explores a number of drug development and delivery models for the Canadian government to consider implementing as it looks to improve access to essential medicines both domestically and internationally. Four market-level case studies focus on innovative financing and collaborative initiatives as ways to enhance Canadas global standing on pharmaceutical R&D. One patient-level case study considers international legislation as a model to improve Canadas purchasing power.",

author = "Wojciech Copija and Lauren Degabriele and M Hosseini and Ashley Schram and {Tshiama Kalonji}, Liliane",

year = "2016",

language = "English",

isbn = "978-0-9951601-2-5",

}

TY - BOOK

T1 - Opportunities for Canada to Improve Global Access to Medicines

AU - Copija, Wojciech

AU - Degabriele, Lauren

AU - Hosseini, M

AU - Schram, Ashley

AU - Tshiama Kalonji, Liliane

PY - 2016

Y1 - 2016

N2 - This report explores a number of drug development and delivery models for the Canadian government to consider implementing as it looks to improve access to essential medicines both domestically and internationally. Four market-level case studies focus on innovative financing and collaborative initiatives as ways to enhance Canadas global standing on pharmaceutical R&D. One patient-level case study considers international legislation as a model to improve Canadas purchasing power.

AB - This report explores a number of drug development and delivery models for the Canadian government to consider implementing as it looks to improve access to essential medicines both domestically and internationally. Four market-level case studies focus on innovative financing and collaborative initiatives as ways to enhance Canadas global standing on pharmaceutical R&D. One patient-level case study considers international legislation as a model to improve Canadas purchasing power.

M3 - Commissioned report

SN - 978-0-9951601-2-5

BT - Opportunities for Canada to Improve Global Access to Medicines

CY - Ottawa, Canada

ER -

Opportunities for Canada to Improve Global Access to Medicines

Abstract

Fingerprint

Cite this